Boughan, Kirsten M.
Caimi, Paolo F.
Article History
First Online: 23 May 2019
Compliance with Ethical Standards
:
: Kirsten M. Boughan declares that she has no conflict of interest. Paolo F. Caimi has received research funding from Genentech; has received compensation for participation on advisory boards from Genentech, Fate Therapeutics, and Kite Pharma; and has received compensation from Celgene for service on a speaker’s bureau.
: This article does not contain any studies with human or animal subjects performed by any of the authors.